Xiao-Ping Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiao-Ping Wang has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Jing Li
Shaanxi Univ Chinese Med, Coll Pharm, 1 Middle Sect Century Ave, Xianyang 712046, Peoples R China
4 shared publicationsSu Gao
College of pharmacy, Shaanxi University of Chinese Medicine , Xianyang 712046 , China
4 shared publicationsHui-Hui Zhou
Shaanxi Univ Chinese Med, Coll Pharm, 1 Middle Sect Century Ave, Xianyang 712046, Peoples R China
3 shared publicationsJi-Qing Bai
Shaanxi Univ Chinese Med, Coll Pharm, 1 Middle Sect Century Ave, Xianyang 712046, Peoples R China
3 shared publications- Ji-Qing Bai
College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, China
3 shared publications Na Li
College of pharmacy, Shaanxi University of Chinese Medicine , Xianyang 712046 , China
3 shared publications
Latest Publications
- Open Access
- 1 January 2024
- Published by TMR Publishing Group in Traditional Medicine Research
- Vol. 9 (4) , 21
Exploring the effects of Danshen-Honghua herb pair on the intestinal flora of rats with acute myocardial ischemia and its microbial transformation in vitro
- 1 January 2024
- Published by TMR Publishing Group in Traditional Medicine Research
- Vol. 9 (4) , 21
Open AccessExploring the effects of Danshen-Honghua herb pair on the intestinal flora of rats with acute myocardial ischemia and its microbial transformation in vitro
- 14 December 2023
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 371
Metagenomic sequencing revealed the regulative effect of Danshen and Honghua herb pair on the gut microbiota in rats with myocardial ischemia injury
In recent years, more and more evidence has shown that the disorder of gut microbiota (GM) is closely correlated with myocardial ischemia (MI). Even though Danshen and Honghua herb pair (DHHP) is widely used in treating cardiovascular disease in China and exhibits obvious clinical efficacy on MI, the anti-MI mechanism of DHHP remains and needs to be explored in depth. Thus, in this study, we investigated whether the amelioration effect and molecular mechanism of DHHP on MI was related to regulating GM through pharmacodynamics evaluation and metagenomic sequencing. Histopathological observation results indicated that DHHP treatment could alleviate the pathological changes of myocardial tissue in the acute myocardial ischemia (AMI) rats induced by isoproterenol (ISO) exhibited some pathological changes, especially structural disorder, irregular distribution, and enlargement of the myocardial space. These pathological changes were all alleviated to some extent by DHHP treatment. Biochemical analysis results suggested that compared with the control group, the serum levels of AST, CTn-I, CK-MB, TNF-α in model group rats were notably decreased, and the CAT and SOD level in serum were markedly increased. These abnormal trends were significantly reversed by DHHP treatment. Furthermore, metagenomic sequencing analysis results indicated DHHP could improve disorders in the composition and function of GM in AMI rats, mainly reflected in increasing diversity and richness, and obviously enhancing the abundance of Bacteroides fluxus, Bacteroides uniformis, Bacteroides stercoris, Roseburia hominis, Schaedlerella arabinosiphila and Roseburia intestinalis, and reducing the abundance of Enterococcus avium and Enterococcus canintestini, which were associated with purine metabolism, tyrosine metabolism, cyanoamino acid metabolism, and glutathione metabolism. In conclusion, DHHP may attenuate ISO-induced MI by regulating the structure, composition, and function of GM, thus contributing to further our understanding of the anti-MI mechanisms of DHHP and provide new therapeutic ideas and diagnostic targets for the clinical studies of MI.
- 14 December 2023
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 371
Metagenomic sequencing revealed the regulative effect of Danshen and Honghua herb pair on the gut microbiota in rats with myocardial ischemia injury
In recent years, more and more evidence has shown that the disorder of gut microbiota (GM) is closely correlated with myocardial ischemia (MI). Even though Danshen and Honghua herb pair (DHHP) is widely used in treating cardiovascular disease in China and exhibits obvious clinical efficacy on MI, the anti-MI mechanism of DHHP remains and needs to be explored in depth. Thus, in this study, we investigated whether the amelioration effect and molecular mechanism of DHHP on MI was related to regulating GM through pharmacodynamics evaluation and metagenomic sequencing. Histopathological observation results indicated that DHHP treatment could alleviate the pathological changes of myocardial tissue in the acute myocardial ischemia (AMI) rats induced by isoproterenol (ISO) exhibited some pathological changes, especially structural disorder, irregular distribution, and enlargement of the myocardial space. These pathological changes were all alleviated to some extent by DHHP treatment. Biochemical analysis results suggested that compared with the control group, the serum levels of AST, CTn-I, CK-MB, TNF-α in model group rats were notably decreased, and the CAT and SOD level in serum were markedly increased. These abnormal trends were significantly reversed by DHHP treatment. Furthermore, metagenomic sequencing analysis results indicated DHHP could improve disorders in the composition and function of GM in AMI rats, mainly reflected in increasing diversity and richness, and obviously enhancing the abundance of Bacteroides fluxus, Bacteroides uniformis, Bacteroides stercoris, Roseburia hominis, Schaedlerella arabinosiphila and Roseburia intestinalis, and reducing the abundance of Enterococcus avium and Enterococcus canintestini, which were associated with purine metabolism, tyrosine metabolism, cyanoamino acid metabolism, and glutathione metabolism. In conclusion, DHHP may attenuate ISO-induced MI by regulating the structure, composition, and function of GM, thus contributing to further our understanding of the anti-MI mechanisms of DHHP and provide new therapeutic ideas and diagnostic targets for the clinical studies of MI.
- Open Access
- 18 April 2022
- Published by Springer Nature in Research Square
Revealing the mechanism of Salvia miltiorrhiza Bunge and Carthamus tinctorius L herb pair in treating myocardial ischemia by combined network pharmacology and experimental verification
The present work was aimed to gain more insight into the molecular mechanisms of Salvia miltiorrhiza Bunge and Carthamus tinctorius L herb pair (SMCTHP) in treating myocardial ischemia (MI) through network pharmacology and in vivo experiments. Firstly, various electronic databases and literatures-mining were utilized to acquire and screen out the bioactive compounds of SMCTHP and potential therapeutic targets of myocardial ischemia (MI). Subsequently, functional enrichment analysis was carried out to obtain a more radical understanding of SMCTHP against MI via the DAVID database. PPI network was established and analyzed to determine the hub targets. Finally, we used the acute myocardial ischemia (AMI) rat model to evaluate the cardioprotective effects of SMCTHP, and TUNEL assay and Western blotting analysis were used to measure the apoptotic rate and validated the hub targets and key pathways, respectively. A total of 92 bioactive compounds of SMCTHP and 245 overlapping targets between SMCTHP and MI were identified from these databases. By performing functional enrichment analysis, the anti-MI targets of SMCTHP were highly correlated with the apoptosis process, and the key functional pathways may be the PI3K/AKT and NF-κB pathways. Then, the hub targets of the PPI network contained AKT1, IL6, TNF, VEGFA, MAPK1, STAT3, RELA, MMP9, CASP3, and TLR4. In vivo experiment demonstrated that SMCTHP significantly improved myocardial ischemic injury, reduced cardiomyocyte apoptosis in ischemic rat myocardium. In addition, SMCTHP could markedly upregulate the expression of phosphorylated (p)-AKT, and obviously downregulated the expressions of TLR4 and p-NF-κBp65 in the myocardial tissue of AMI rats. This study revealed that SMCTHP may ameliorate ISO-induced myocardial ischemic injury via exhibiting the anti-apoptotic effects potentially be regulating the AKT and TLR4/NF-κB pathways.
- 18 April 2022
- Published by Springer Nature in Research Square
Open AccessRevealing the mechanism of Salvia miltiorrhiza Bunge and Carthamus tinctorius L herb pair in treating myocardial ischemia by combined network pharmacology and experimental verification
The present work was aimed to gain more insight into the molecular mechanisms of Salvia miltiorrhiza Bunge and Carthamus tinctorius L herb pair (SMCTHP) in treating myocardial ischemia (MI) through network pharmacology and in vivo experiments. Firstly, various electronic databases and literatures-mining were utilized to acquire and screen out the bioactive compounds of SMCTHP and potential therapeutic targets of myocardial ischemia (MI). Subsequently, functional enrichment analysis was carried out to obtain a more radical understanding of SMCTHP against MI via the DAVID database. PPI network was established and analyzed to determine the hub targets. Finally, we used the acute myocardial ischemia (AMI) rat model to evaluate the cardioprotective effects of SMCTHP, and TUNEL assay and Western blotting analysis were used to measure the apoptotic rate and validated the hub targets and key pathways, respectively. A total of 92 bioactive compounds of SMCTHP and 245 overlapping targets between SMCTHP and MI were identified from these databases. By performing functional enrichment analysis, the anti-MI targets of SMCTHP were highly correlated with the apoptosis process, and the key functional pathways may be the PI3K/AKT and NF-κB pathways. Then, the hub targets of the PPI network contained AKT1, IL6, TNF, VEGFA, MAPK1, STAT3, RELA, MMP9, CASP3, and TLR4. In vivo experiment demonstrated that SMCTHP significantly improved myocardial ischemic injury, reduced cardiomyocyte apoptosis in ischemic rat myocardium. In addition, SMCTHP could markedly upregulate the expression of phosphorylated (p)-AKT, and obviously downregulated the expressions of TLR4 and p-NF-κBp65 in the myocardial tissue of AMI rats. This study revealed that SMCTHP may ameliorate ISO-induced myocardial ischemic injury via exhibiting the anti-apoptotic effects potentially be regulating the AKT and TLR4/NF-κB pathways.
- 29 March 2022
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 369 (1)
Modulation effects of danshen-honghua herb pair on gut microbiota of acute myocardial ischemia model rat
In the recent years, a growing number of studies have shown that the occurrence of myocardial ischemia (MI) is closely related to the gut microbiota (GM). The Danshen-Honghua herb pair (DHHP), a classic combination in traditional Chinese herbal formulas, has been widely applied throughout history to cure cardiovascular disease, exhibiting remarkable clinical efficacy to treat ischemic heart disease (IHD). However, the intrinsic regulation mechanism of DHHP in treating MI remains unclear. This study aims to investigate the possible protective mechanism of DHHP in rats with acute myocardial ischemia (AMI) induced by isoproterenol (ISO) through 16S rRNA gene sequencing technique. Pharmacodynamic results showed that DHHP significantly ameliorated the pathological changes and improved the abnormal cardiac enzymes levels in the AMI rats. In addition, GM analysis demonstrated that DHHP effectively ameliorated the ISO-induced dysbiosis of the GM community, mainly by enhancing the GM diversity and increasing the relative abundance of Bacteroides, Roseburia, unclassified_f__Lachnospiraceae, and Lachnospiraceae_NK4A136_group, the abundance ratio of Bacteroidetes to Firmicutes, and decreasing the relative abundance of Escherichia-Shigella and Enterococcus. In summary, this study revealed that DHHP could improve ischemic myocardial injury in rats, and that its regulation mechanism is associated with significantly ameliorating the composition of GM, thus contributing to further our understanding of the anti-MI mechanisms of DHHP.
- 29 March 2022
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 369 (1)
Modulation effects of danshen-honghua herb pair on gut microbiota of acute myocardial ischemia model rat
In the recent years, a growing number of studies have shown that the occurrence of myocardial ischemia (MI) is closely related to the gut microbiota (GM). The Danshen-Honghua herb pair (DHHP), a classic combination in traditional Chinese herbal formulas, has been widely applied throughout history to cure cardiovascular disease, exhibiting remarkable clinical efficacy to treat ischemic heart disease (IHD). However, the intrinsic regulation mechanism of DHHP in treating MI remains unclear. This study aims to investigate the possible protective mechanism of DHHP in rats with acute myocardial ischemia (AMI) induced by isoproterenol (ISO) through 16S rRNA gene sequencing technique. Pharmacodynamic results showed that DHHP significantly ameliorated the pathological changes and improved the abnormal cardiac enzymes levels in the AMI rats. In addition, GM analysis demonstrated that DHHP effectively ameliorated the ISO-induced dysbiosis of the GM community, mainly by enhancing the GM diversity and increasing the relative abundance of Bacteroides, Roseburia, unclassified_f__Lachnospiraceae, and Lachnospiraceae_NK4A136_group, the abundance ratio of Bacteroidetes to Firmicutes, and decreasing the relative abundance of Escherichia-Shigella and Enterococcus. In summary, this study revealed that DHHP could improve ischemic myocardial injury in rats, and that its regulation mechanism is associated with significantly ameliorating the composition of GM, thus contributing to further our understanding of the anti-MI mechanisms of DHHP.
- Open Access
- 27 January 2021
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 59 (1) , 333-344
Study on the protective effects of danshen-honghua herb pair (DHHP) on myocardial ischaemia/reperfusion injury (MIRI) and potential mechanisms based on apoptosis and mitochondria
Danshen, the dried root and rhizome of Salvia miltiorrhiza Bunge (Labiatae) and honghua, the dried flower of Carthamus tinctorius L. (Compositae) as the herb pair was used to treat cardiovascular d...
- 27 January 2021
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 59 (1) , 333-344
Open AccessStudy on the protective effects of danshen-honghua herb pair (DHHP) on myocardial ischaemia/reperfusion injury (MIRI) and potential mechanisms based on apoptosis and mitochondria
Danshen, the dried root and rhizome of Salvia miltiorrhiza Bunge (Labiatae) and honghua, the dried flower of Carthamus tinctorius L. (Compositae) as the herb pair was used to treat cardiovascular d...
- Open Access
- 1 October 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 118, 109268
Investigating the effects and possible mechanisms of danshen- honghua herb pair on acute myocardial ischemia induced by isoproterenol in rats
- 1 October 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 118, 109268
Open AccessInvestigating the effects and possible mechanisms of danshen- honghua herb pair on acute myocardial ischemia induced by isoproterenol in rats
- Open Access
The Comprehensive Evaluation of Safflowers in Different Producing Areas by Combined Analysis of Color, Chemical Compounds, and Biological Activity
In the present study, a new strategy including the combination of external appearance, chemical detection, and biological analysis was proposed for the comprehensive evaluation of safflowers in different producing areas. Firstly, 40 batches of safflower samples were classified into class I and II based on color measurements and K-means clustering analysis. Secondly, a rapid and sensitive analytical method was developed for simultaneous quantification of 16 chromaticity-related characteristic components (including characteristic components hydroxysafflor yellow A, anhydrosafflor yellow B, safflomin C, and another 13 flavonoid glycosides) in safflowers by ultra-performance liquid chromatography coupled with triple-quadrupole linear ion-trap tandem mass spectrometry (UPLC-QTRAP®/MS2). The results of the quantification indicate that hydroxysafflor yellow A, anhydrosafflor yellow B, kaempferol, quercetin, and safflomin C had significant differences between the two types of safflower, and class I of safflower had a higher content of hydroxysafflor yellow A, anhydrosafflor yellow B, and safflomin C as the main anti-thrombotic components in safflower. Thirdly, chemometrics methods were employed to illustrate the relationship in multivariate data of color measurements and chromaticity-related characteristic components. As a result, kaempferol-3-O-rutinoside and 6-hydroxykaempferol-3-O-β-d-glucoside were strongly associated with the color indicators. Finally, anti-thrombotic analysis was used to evaluate activity and verify the suitability of the classification basis of safflower based on the color measurements. It was shown that brighter, redder, yellower, more orange–yellow, and more vivid safflowers divided into class I had a higher content of characteristic components and better anti-thrombotic activity. In summary, the presented strategy has potential for quality evaluation of other flower medicinal materials.
Open AccessThe Comprehensive Evaluation of Safflowers in Different Producing Areas by Combined Analysis of Color, Chemical Compounds, and Biological Activity
In the present study, a new strategy including the combination of external appearance, chemical detection, and biological analysis was proposed for the comprehensive evaluation of safflowers in different producing areas. Firstly, 40 batches of safflower samples were classified into class I and II based on color measurements and K-means clustering analysis. Secondly, a rapid and sensitive analytical method was developed for simultaneous quantification of 16 chromaticity-related characteristic components (including characteristic components hydroxysafflor yellow A, anhydrosafflor yellow B, safflomin C, and another 13 flavonoid glycosides) in safflowers by ultra-performance liquid chromatography coupled with triple-quadrupole linear ion-trap tandem mass spectrometry (UPLC-QTRAP®/MS2). The results of the quantification indicate that hydroxysafflor yellow A, anhydrosafflor yellow B, kaempferol, quercetin, and safflomin C had significant differences between the two types of safflower, and class I of safflower had a higher content of hydroxysafflor yellow A, anhydrosafflor yellow B, and safflomin C as the main anti-thrombotic components in safflower. Thirdly, chemometrics methods were employed to illustrate the relationship in multivariate data of color measurements and chromaticity-related characteristic components. As a result, kaempferol-3-O-rutinoside and 6-hydroxykaempferol-3-O-β-d-glucoside were strongly associated with the color indicators. Finally, anti-thrombotic analysis was used to evaluate activity and verify the suitability of the classification basis of safflower based on the color measurements. It was shown that brighter, redder, yellower, more orange–yellow, and more vivid safflowers divided into class I had a higher content of characteristic components and better anti-thrombotic activity. In summary, the presented strategy has potential for quality evaluation of other flower medicinal materials.